Provenienza dei contatti di primo grado di Delphine Davan
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
29
| Public Company | Biotechnology | 29 |
| Public Company | Biotechnology | 15 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Delphine Davan tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| TELESTA THERAPEUTICS INC | Pharmaceuticals: Other | Director/Board Member Corporate Officer/Principal | |
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal General Counsel | |
| TRUE NORTH COMMERCIAL REAL ESTATE INVESTMENT TRUST | Real Estate Investment Trusts | Director/Board Member | |
| Acadia University | College/University | Undergraduate Degree | |
| Brandeis University | College/University | Graduate Degree Undergraduate Degree | |
| Memorial University of Newfoundland | College/University | Graduate Degree Undergraduate Degree | |
| University of Toronto | College/University | Undergraduate Degree Masters Business Admin | |
| University of Western Ontario | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Graduate Degree | |
| University of South Florida | College/University | Undergraduate Degree | |
| Wesleyan University | College/University | Undergraduate Degree | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Private Equity Investor | |
| L'Université d'Angers | College/University | Graduate Degree | |
| Université Laval | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Graduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
| TRICON CAPITAL GROUP | Real Estate Development | Director/Board Member | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Pacrim Hospitality Services, Inc.
 Pacrim Hospitality Services, Inc. Hotels/Resorts/Cruise linesConsumer Services Pacrim Hospitality Services, Inc. operates as a hotel management and development company. It provides management, operational, and consulting services. The company was founded on December 22, 2004 and is headquartered in Calgary, Canada. | Hotels/Resorts/Cruise lines | Director of Finance/CFO | |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Aztec Components, Inc.
 Aztec Components, Inc. Electronics DistributorsDistribution Services Aztec Components, Inc. distributes electronic components, semiconductors and peripherals. It supplies passive and peripheral components. The company was founded in 1996 and is headquartered in Vista, CA. | Electronics Distributors | Corporate Officer/Principal | |
| Intelligene Expressions, Inc. | Founder Founder | ||
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Director of Finance/CFO | |
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
JEG & Associates LLC
 JEG & Associates LLC Miscellaneous Commercial ServicesCommercial Services JEG & Associates LLC provides legal services. The private company is based in Suisun City, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Consortium Québécois sur la Découverte du Médicament
 Consortium Québécois sur la Découverte du Médicament Miscellaneous Commercial ServicesCommercial Services Consortium Québécois sur la Découverte du Médicament (CQDM) is a not-for-profit biopharmaceutical research consortium based in Montréal, Canada. CQDM's mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM funds the development of innovative tools and technologies that accelerate the discovery and development of safer and more effective drugs. The company's Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. CQDM's SynergiQC-International program is designed to promote university-based industrial research in the biopharmaceutical field with collaborators outside, that will generate economic benefits. The non-profit company was founded by Max Fehlmann. | Miscellaneous Commercial Services | Director/Board Member | |
Medicenna Therapeutics, Inc.
 Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Founder | |
Beatrice Hunter Cancer Research Institute
 Beatrice Hunter Cancer Research Institute Miscellaneous Commercial ServicesCommercial Services Beatrice Hunter Cancer Research Institute operates as virtual cancer research institute. It discovers ways to prevent cancer progression and metastasis. The company was founded in 2009 and is headquartered in St. Halifax, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| RELAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Starlight Group Property Holdings, Inc.
 Starlight Group Property Holdings, Inc. Financial ConglomeratesFinance Starlight Group Property Holdings, Inc. is a Canadian real estate company that specializes in multi-family and single-family properties. The private company is based in Toronto, CA. The company focuses on areas with strong population, economic, and employment rates. The company has institutional partnerships and a leadership team. Starlight has a history timeline and a multi-family home page. The company also has a multi-family (no. 1) value-add fund and a multi-family portfolio. and has subsidiaries in United States and Canada. The CEO of the company is Daniel Drimmer. | Financial Conglomerates | Director of Finance/CFO | |
| PURE GLOBAL CANNABIS INC. | Pharmaceuticals: Other | Chairman Director/Board Member | |
Monte Rosa Therapeutics AG
 Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Monte Rosa Therapeutics AG develops, manufactures and distributes cancer drugs that modulate protein degradation pathways. The company was founded in 2018 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
Rome Therapeutics, Inc.
 Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO | |
Ventus Therapeutics, Inc.
 Ventus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ventus Therapeutics, Inc. operates as a biopharmaceutical company. It focuses in developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases and cancer. The company was founded by Hao Wu, Richard Flavell, Judy Lieberman, Thomas Tuschl, and Feng Shao and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Ventus Therapeutics U.S., Inc.
 Ventus Therapeutics U.S., Inc. Medical DistributorsDistribution Services Ventus Therapeutics U.S., Inc. operates as a biotechnology company. The company is headquartered in Natick, MA. | Medical Distributors | Director/Board Member | |
| MONTE ROSA THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
| TRELLUS HEALTH PLC | Internet Software/Services | Director of Finance/CFO | |
| VM HOTEL ACQUISITION CORP. | Financial Conglomerates | Founder |
Statistiche
Distribuzione geografica
| Stati Uniti | 24 |
| Canada | 20 |
| Francia | 3 |
| Islanda | 2 |
| Hong Kong | 2 |
Settori
| Health Technology | 20 |
| Consumer Services | 15 |
| Commercial Services | 7 |
| Finance | 6 |
| Distribution Services | 3 |
Posizioni
| Director/Board Member | 119 |
| Corporate Officer/Principal | 72 |
| Independent Dir/Board Member | 44 |
| Director of Finance/CFO | 32 |
| Undergraduate Degree | 31 |
Contatti più connessi
| Insiders | |
|---|---|
| Julia Gregory | 22 |
| Chandrakant Panchal | 22 |
| Karen Dawes | 22 |
| Pierre Labbé | 19 |
| Shermaine Tilley | 17 |
| James Hall | 16 |
| Wayne Pisano | 14 |
| David Hyman | 12 |
| Jack Geltosky | 11 |
| Albert Beraldo | 11 |
| Markus Warmuth | 11 |
| Tracy Sherren | 11 |
| Fahar Merchant | 10 |
| Humphrey Gardner | 9 |
| Kyle Kuvalanka | 8 |
- Borsa valori
- Insiders
- Delphine Davan
- Connessioni Società
